Supernus Pharmaceuticals CEO sells $1.39 million in stock
NeutralFinancial Markets

The CEO of Supernus Pharmaceuticals has sold $1.39 million worth of stock, a move that raises questions about the company's future direction and the CEO's confidence in its performance. Such transactions can impact investor sentiment and market perception, making it a noteworthy event for stakeholders.
— Curated by the World Pulse Now AI Editorial System